Trial Profile
A prospective, observational study assessing the effect of Sitagliptin on cognitive functions in elderly patients with Type II Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Mar 2017
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Mar 2017 New trial record